Clinical Trial Update: A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating STEMVAC in combination with standard endocrine therapy or chemotherapy for metastatic hormone receptor-positive, HER2-negative breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• STEMVAC

Snippet

Sponsor: University of Washington | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma | Phase 2 | Status: RECRUITING